Skip to content

Observational Study Evaluating the Use of Intellivent® for Patients With Respiratory Distress Syndrome

Etude Clinique Observationnelle, Prospective, Ouverte, Monocentrique Sur l'Utilisation d'un Mode Ventilatoire entièrement automatisé Chez Les Patients de réanimation de l'Intubation Jusqu'au Sevrage.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01489085
Acronym
intellivent
Enrollment
100
Registered
2011-12-09
Start date
2013-01-31
Completion date
2013-04-30
Last updated
2014-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Distress Syndrome

Keywords

ventilation, automated

Brief summary

Rational: Intellivent is a ventilation mode completely automated which controls ventilation and oxygenation parameters. Safety and performance of IntelliVent has still been demonstrated in post operative heart surgery for patient with a controlled ventilation on short period (2 to 4 hours). This feasibility study evaluate the use of Intellivent for Intensive care unit patients from intubation to coming off. Primary objective : Compare parameters which have been selected by automated mod (Intellivent) to those selected by clinical practitioner in a conventional mode Secondary objectives: Record oxygenation , gaseous interchange and ventilation parameters. Record complications, number of manual adjustments and prognostic signs. Methodology: Patients in the intensive care unit who need invasive ventilation. They will be included after a detailed information (information note). Oxygenation and ventilation parameters will be recorded 2 times by day from intubation to coming off. The investigator in charge will determine daily at the bedside of the patient the adjustments he should make in a conventional mode. These adjustments will be compared to the IntelliVent automated adjustments. Experimental study, observational, prospective, comparative, opened, monocentric in an intensive care unit. Number of patients: 100

Interventions

None listed

Sponsors

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient which needs an invasive ventilation * Intubation \< 24 hours * Age ≥ 18 years

Exclusion criteria

* Patient which has withdrawal standard in line with the unit coming off procedure (all criteria must be present) * temperature ≤ 38,5°C * No pressor drug * No sedation, * Motor response to order, * Cough during bronchoaspiration * %VM ≤ 130%, FiO2 ≤ 50%, PEEP ≤ 5 cmH2O, Pinsp ≤ 25 cmH2O. * Patient with non invasive ventilation . * Dysfunctions of the ventilatory command (ex Cheyne-Stokes). * Broncho pleural fistula. * Brain dead status. * Pregnant woman. * Adult under guardianship. * Person deprived of liberty

Design outcomes

Primary

MeasureTime frameDescription
oxygenation , gaseous interchange and ventilation parametersParticipants are followed until they no longer need ventilation up to 10 daysRecord oxygenation , gaseous interchange and ventilation parameters

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026